Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.

Finasteride may cause breast enlargement, low testosterone a risk factor.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

The document does not confirm if radical prostatectomy is the best treatment for locally advanced prostate cancer.

Serum triglyceride levels are not linked to prostate cancer risk.

Personalized treatment is crucial for effectively managing benign prostatic hyperplasia (BPH).

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Saw palmetto helps with nighttime urination and urine flow, similar to finasteride.

Finasteride can treat prostatic haematuria, but its use is controversial.

Robotic surgery improves patient safety and surgical quality.

Personalized, minimally invasive treatments improve urology outcomes.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

More biopsy cores and MRI before biopsy can improve prostate cancer detection.

A new score can help predict which patients might have trouble urinating after prostate surgery.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

Intraprostatic injection and high-frequency thermotherapy are more effective for treating prostatitis after TURP than antibiotics, tamsulosin, and finasteride.

TURP specimens should be checked for various tumors, not just common prostate issues.

Photoacoustic imaging can detect prostate brachytherapy seeds better with enhanced contrast methods, but depth limits remain.

Taking finasteride before surgery reduces blood loss in prostate procedures.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Patients with metabolic syndrome had lower Gleason scores when diagnosed with prostate cancer.